medical student[1]
study financial toxicity and how it affects lymphoma patients · studying financial toxicity and other cancers · Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma— the cost-effectiveness and impact on patients if radiation therapy is omitted.
Reviewed sources document Education record: She earned her undergraduate degree from University of Pennsylvania.
Explore education and trainingReviewed sources document study financial toxicity and how it affects lymphoma patients, studying financial toxicity and other cancers, and Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma— the cost-effectiveness and impact on patients if radiation therapy is omitted.. Explore attributed publications and research affiliations.
Explore researchmedical student[1]
She earned her undergraduate degree from University of Pennsylvania[1]
study financial toxicity and how it affects lymphoma patients[1]
studying financial toxicity and other cancers[1]
Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma— the cost-effectiveness and impact on patients if radiation therapy is omitted.[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
6 source claims · Reviewed Sep 9, 2026
Education record: She earned her undergraduate degree from University of Pennsylvania
She earned her undergraduate degree from University of Pennsylvania in the subject
Identity: Victoria Wu
Third-year Case Western Reserve University medical student Victoria Wu knows a thing or two about economics. She earned her undergraduate degree from University of Pennsylvania in the subject, and is using that expertise to study financial toxicity and how it affects lymphoma patients. It’s research she will soon present at the American Society of Clinical Oncology (ASCO) Quality Care Symposium. Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma— the cost-effectiveness and impact on patients if radiation therapy is omitted. “We looked at what the patients would pay out-of-pocket instead of traditional cost-effective analyses that look at the hospital payer perspective,” said Wu. She explains financial toxicity in simple terms. “It’s thinking about cancer costs from a broad perspective,” said Wu. “Cancer treatments have a cost—but there is so much more involved—lost wages due to time off work, caregiving costs, transportation to treatments and much more. It's the accumulation of these high costs that can create harmful effects on a patient's quality of life.” Wu will present her lymphoma care abstract at the ASCO symposium in October, but she is also studying financial toxicity and other cancers.
Professional role: medical student
Third-year Case Western Reserve University medical student Victoria Wu knows a thing or two about economics. She earned her undergraduate degree from University of Pennsylvania in the subject, and is using that expertise to study financial toxicity and how it affects lymphoma patients. It’s research she will soon present at the American Society of Clinical Oncology (ASCO) Quality Care Symposium. Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma— the cost-effectiveness and impact on patients if radiation therapy is omitted. “We looked at what the patients would pay out-of-pocket instead of traditional cost-effective analyses that look at the hospital payer perspective,” said Wu. She explains financial toxicity in simple terms. “It’s thinking about cancer costs from a broad perspective,” said Wu. “Cancer treatments have a cost—but there is so much more involved—lost wages due to time off work, caregiving costs, transportation to treatments and much more. It's the accumulation of these high costs that can create harmful effects on a patient's quality of life.” Wu will present her lymphoma care abstract at the ASCO symposium in October, but she is also studying financial toxicity and other cancers.
Research interests: study financial toxicity and how it affects lymphoma patients
and is using that expertise to study financial toxicity and how it affects lymphoma patients.
Research interests: studying financial toxicity and other cancers
but she is also studying financial toxicity and other cancers.
Research interests: Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma— the cost-effectiveness and impact on patients if radiation therapy is omitted.
Third-year Case Western Reserve University medical student Victoria Wu knows a thing or two about economics. She earned her undergraduate degree from University of Pennsylvania in the subject, and is using that expertise to study financial toxicity and how it affects lymphoma patients. It’s research she will soon present at the American Society of Clinical Oncology (ASCO) Quality Care Symposium. Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma— the cost-effectiveness and impact on patients if radiation therapy is omitted. “We looked at what the patients would pay out-of-pocket instead of traditional cost-effective analyses that look at the hospital payer perspective,” said Wu. She explains financial toxicity in simple terms. “It’s thinking about cancer costs from a broad perspective,” said Wu. “Cancer treatments have a cost—but there is so much more involved—lost wages due to time off work, caregiving costs, transportation to treatments and much more. It's the accumulation of these high costs that can create harmful effects on a patient's quality of life.” Wu will present her lymphoma care abstract at the ASCO symposium in October, but she is also studying financial toxicity and other cancers.